Short Interest in InnoCare Pharma Limited (OTCMKTS:INCPF) Grows By 7.9%

InnoCare Pharma Limited (OTCMKTS:INCPF) was the target of a large increase in short interest in the month of June. As of June 15th, there was short interest totalling 3,096,000 shares, an increase of 7.9% from the May 31st total of 2,868,000 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

InnoCare Pharma Price Performance

INCPF stock remained flat at $3.26 on Tuesday. The company had a trading volume of 12,000 shares, compared to its average volume of 3,450. InnoCare Pharma has a one year low of $3.26 and a one year high of $3.72. The firm’s 50 day simple moving average is $3.26 and its two-hundred day simple moving average is $3.26.

About InnoCare Pharma

InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases. It develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom's macroglobulinemia, r/r marginal zone lymphoma, r/r diffuse large B-cell lymphoma (DLBCL)- MCD, r/r central nervous system lymphoma, combo w/MIL-62, systemic lupus erythematosus, immune thrombocytopenia purpura, multiple sclerosis, and neuromyelitis optica spectrum disorder.